Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (15)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Aicher, W. K.
Right arrow Articles by Eibel, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aicher, W. K.
Right arrow Articles by Eibel, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

International Immunology, Vol. 11, No. 1, 47-61, January 1999
© 1999 Japanese Society for Immunology

Serum response elements activate and cAMP responsive elements inhibit expression of transcription factor Egr-1 in synovial fibroblasts of rheumatoid arthritis patients

Wilhelm K. Aicher, Adelheid Dinkel, Bodo Grimbacher, Christian Haas, Elisabeth v. Seydlitz-Kurzbach, Hans H. Peter and Hermann Eibel

Clinical Research Unit for Rheumatology and Department of Rheumatology and Clinical Immunology, University Hospital Freiburg, 79106 Freiburg, Germany

Correspondence to: H. Eibel, Clinical Research Unit for Rheumatology, University Hospital Freiburg, Breisacher Strasse 64, 79106 Freiburg, Germany

Analyzing the induction kinetics and promoter elements regulating the expression of the transcription factor Egr-1, we found elevated levels of Egr-1-encoding mRNA in synovial fibroblasts of rheumatoid arthritis (RA) patients when compared to controls. By contrast, synovial lymphocytes and macrophages do not show an elevated Egr-1 transcription. Therefore, the overexpression of Egr-1 may serve as a diagnostic marker to characterize synovial fibroblasts of RA patients. To study the regulatory mechanisms controlling Egr-1 expression we analyzed the function of transcription factor binding sites located in the Egr-1 promoter. Individual transcription factor binding sites within the Egr-1 promoter were specifically mutated and Egr-1 promoter activity was tested using reporter gene constructs. Our experiments demonstrate that serum response elements are the main positive regulators and binding to a cAMP responsive element represents the major negative regulator for Egr-1 expression in synovial fibroblasts. In addition, we functionally defined a new element, which was not yet described in the human Egr-1 promoter and which serves as a second negative regulatory element for Egr-1 expression. Therefore increased serum response factor activity or failure of Egr-1 repressing signals may account for Egr-1 overexpression in RA synovial fibroblasts.

Keywords: autoimmune disease, c-fos, Egr-1, rheumatoid arthritis, transcription factor

Transmitting editor: K. Eichmann


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J Biomol ScreenHome page
Y. Ibold, S. Frauenschuh, C. Kaps, M. Sittinger, J. Ringe, and P. M. Goetz
Development of a High-Throughput Screening Assay Based on the 3-Dimensional Pannus Model for Rheumatoid Arthritis
J Biomol Screen, October 1, 2007; 12(7): 956 - 965.
[Abstract] [PDF]


Home page
Mol. Endocrinol.Home page
W. R. Duan, M. Ito, Y. Park, E. T. Maizels, M. Hunzicker-Dunn, and J. L. Jameson
GnRH Regulates Early Growth Response Protein 1 Transcription Through Multiple Promoter Elements
Mol. Endocrinol., February 1, 2002; 16(2): 221 - 233.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
I. Lavelin, N. Meiri, O. Genina, R. Alexiev, and M. Pines
Na+-K+-ATPase gene expression in the avian eggshell gland: distinct regulation in different cell types
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2001; 281(4): R1169 - R1176.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.